IL134880A0 - A method of diagnosis - Google Patents

A method of diagnosis

Info

Publication number
IL134880A0
IL134880A0 IL13488098A IL13488098A IL134880A0 IL 134880 A0 IL134880 A0 IL 134880A0 IL 13488098 A IL13488098 A IL 13488098A IL 13488098 A IL13488098 A IL 13488098A IL 134880 A0 IL134880 A0 IL 134880A0
Authority
IL
Israel
Prior art keywords
predicting
development
lung damage
damage
diagnosing
Prior art date
Application number
IL13488098A
Other languages
English (en)
Original Assignee
Univ Southern Australia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO8999A external-priority patent/AUPO899997A0/en
Priority claimed from AUPP5062A external-priority patent/AUPP506298A0/en
Application filed by Univ Southern Australia filed Critical Univ Southern Australia
Publication of IL134880A0 publication Critical patent/IL134880A0/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Vehicle Body Suspensions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Control Of Eletrric Generators (AREA)
IL13488098A 1997-09-05 1998-09-04 A method of diagnosis IL134880A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO8999A AUPO899997A0 (en) 1997-09-05 1997-09-05 A method of diagnosis
AUPP5062A AUPP506298A0 (en) 1998-08-04 1998-08-04 A method of diagnosis - II
PCT/AU1998/000723 WO1999013337A1 (fr) 1997-09-05 1998-09-04 Procede de diagnostic

Publications (1)

Publication Number Publication Date
IL134880A0 true IL134880A0 (en) 2001-05-20

Family

ID=25645598

Family Applications (3)

Application Number Title Priority Date Filing Date
IL13488098A IL134880A0 (en) 1997-09-05 1998-09-04 A method of diagnosis
IL134880A IL134880A (en) 1997-09-05 2000-03-05 Method of diagnosing lung damage
IL172185A IL172185A0 (en) 1997-09-05 2005-11-24 Method of diagnosis lung damage

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL134880A IL134880A (en) 1997-09-05 2000-03-05 Method of diagnosing lung damage
IL172185A IL172185A0 (en) 1997-09-05 2005-11-24 Method of diagnosis lung damage

Country Status (10)

Country Link
US (1) US8097420B1 (fr)
EP (1) EP1018018B1 (fr)
JP (2) JP4584445B2 (fr)
AT (1) ATE476662T1 (fr)
CA (1) CA2303169C (fr)
DE (1) DE69841804D1 (fr)
DK (1) DK1018018T3 (fr)
IL (3) IL134880A0 (fr)
NZ (1) NZ503175A (fr)
WO (1) WO1999013337A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3935507B2 (ja) 1996-02-28 2007-06-27 松下電器産業株式会社 高解像度および立体映像記録用光ディスク、光ディスク再生装置、光ディスク記録装置
WO2004077056A1 (fr) * 2003-02-27 2004-09-10 Lung Health Diagnostics Pty. Ltd. Methode de diagnostic et agents utilises dans cette methode
SE0203591D0 (sv) * 2002-12-04 2002-12-04 Siemens Elema Ab Förfarande för beredning av ett mediakament och en medicinsk anordning
EP1522857A1 (fr) * 2003-10-09 2005-04-13 Universiteit Maastricht Méthode pour identifier des individus qui risquent de développer une défaillance cardiaque par la détection du taux de galectine-3 ou thrombospondine-2
US7659087B2 (en) * 2004-07-23 2010-02-09 Aspenbio Pharma, Inc. Methods and devices for diagnosis of appendicitis
EP1845379A1 (fr) * 2006-04-13 2007-10-17 F. Hoffmann-La Roche AG Moyens et méthodes pour la distinction entre les causes cardiaques et pulmonaires du syndrome du souffle court
EP1882945A1 (fr) 2006-07-28 2008-01-30 F.Hoffmann-La Roche Ag Procedes et moyens permettant de differenciation entre des causes cardiaques et pulmonaires de dyspnée aiguë
EP2031397A1 (fr) 2007-08-30 2009-03-04 F. Hoffmann-La Roche AG Protéines surfactantes B et D pour la différentiation des causes du manque de souffle
CN101938939B (zh) * 2008-02-07 2014-11-26 皇家飞利浦电子股份有限公司 用于测量和预测患者呼吸稳定性的装置
EP2689252A1 (fr) 2011-03-25 2014-01-29 Roche Diagnostics GmbH Mesure de c-terminal prosp-b
CN102552879B (zh) * 2012-03-15 2013-11-06 北京双鹤现代医药技术有限责任公司 肺表面活性提取物与肺表面活性物质相关蛋白a的组合物、制备方法及其制药用途
EP2650684A1 (fr) 2012-04-10 2013-10-16 Roche Diagniostics GmbH Diagnostic de type pro SP-B et NT-proBNP chez des patients atteints de pneumonie
EP2615459A1 (fr) 2012-04-27 2013-07-17 Roche Diagniostics GmbH Procédé pour le diagnostic du dommage de tissue bronchoalvéolaire distale dans l'asthme par la détection de proSP-B.
EP2866033A1 (fr) 2013-10-23 2015-04-29 Roche Diagniostics GmbH Diagnostic différentiel de la dyspnée aiguë sur la base de proSP-B de terminal C, KL-6 et peptides de type BNP
GB201511207D0 (en) * 2015-06-25 2015-08-12 Xvivo Perfusion Ab Isolated organ evaluation and treatment
EP3287921B1 (fr) * 2016-08-26 2020-11-04 Nxp B.V. Détermination de l'adéquation d'une phrase de passe parlée

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650147T2 (de) 1985-05-31 1995-04-06 Teijin Ltd Verfahren zur bestimmung menschlicher lungenoberflächenaktiver substanz und reagenziensatz dazu.
KR920001533B1 (ko) 1987-09-01 1992-02-18 데이진 가부시끼가이샤 인간 폐표면 활성물질의 측정방법
JP2517696B2 (ja) 1990-04-27 1996-07-24 帝人株式会社 肺疾患マ―カ―蛋白の測定法
IE921342A1 (en) 1991-04-26 1992-11-04 Surface Active Ltd Novel antibodies, and methods for their use
US5670328A (en) * 1992-06-09 1997-09-23 Yamasa Corporation Monoclonal antibodies to human pulmonary surfactant apoprotein D and use thereof
AU4355093A (en) 1992-06-09 1994-01-04 Yamasa Corporation Monoclonal antibody against human lung surfactant apoprotein d and use thereof
WO2000005585A1 (fr) 1998-07-24 2000-02-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Determination de la proteine sp-c hydrophobe du surfactant pulmonaire
US7713705B2 (en) 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof

Also Published As

Publication number Publication date
WO1999013337A1 (fr) 1999-03-18
EP1018018A4 (fr) 2004-12-22
JP2010197405A (ja) 2010-09-09
CA2303169C (fr) 2009-11-10
JP4584445B2 (ja) 2010-11-24
NZ503175A (en) 2002-11-26
JP2001516057A (ja) 2001-09-25
CA2303169A1 (fr) 1999-03-18
US8097420B1 (en) 2012-01-17
DE69841804D1 (de) 2010-09-16
DK1018018T3 (da) 2010-11-15
EP1018018B1 (fr) 2010-08-04
EP1018018A1 (fr) 2000-07-12
IL172185A0 (en) 2009-02-11
HK1029622A1 (en) 2001-04-06
ATE476662T1 (de) 2010-08-15
IL134880A (en) 2006-12-10

Similar Documents

Publication Publication Date Title
IL134880A0 (en) A method of diagnosis
WO2003069332A3 (fr) Detection et/ou surveillance de maladies liees a la synucleine
FR2847267B1 (fr) Procede de test de l'activite d'une substance potentiellement active pour inhiber l'activite enzymatique de la phospholipase a2
WO2002034571A3 (fr) Methode d'evaluation et d'ameliorations du comportement d'un conducteur de vehicule et dispositif a cet effet
ZA964819B (en) Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds.
DE60218863D1 (de) Herz-lungen-überwachungsgerät
DE69935187D1 (de) Diagnoseeinrichtung für Bremskraftverstärker zur optimierten Erkennung von Fehlern des Bremskraftverstärkers
CY1109062T1 (el) Μεθοδοι ανιχνευσεως και αναστολης της αγγειογενεσεως
CA2255023A1 (fr) Methode et systeme de surveillance de l'execution de code source hybride
WO2000018899A3 (fr) Homologue d'enzyme de conversion d'angiotensine et son utilisation
AU6416198A (en) Diagnostic means useful for predictive assessment of human hepatocellular carc inoma disease (hcc), as well as diagnostic methods using the same
SE0101912D0 (sv) a method and an apparatus for measuring functional, residual capacity (FRC) and cardiac output (CO)
DE69404460D1 (de) Zell-test für alzheimersche krankheit
ES2148967T3 (es) Sustancias y metodos destinados al diagnostico y al tratamiento de la pre-eclampsia.
ZA964818B (en) Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds.
FR2344837A1 (fr) Installation d'emission acoustique permettant la detection des defauts de soudage
AU2003217652A8 (en) Methods for continuous performance testing
BR0207548A (pt) Método de controle de poeira automatizado
IL127033A (en) Method for early detection of lysosomal storage disorders and a kit for detecting the same
WO1998041238A3 (fr) Methodes et kits de traitement et de diagnostic de leiomyomes
DE69508605D1 (de) Proinsulin-peptid-verbindungen für den nachweis und die behandlung von typ-i-diabetes
CA2091637A1 (fr) Surveillance d'appels en cours
CA2334910A1 (fr) Nouvelle utilisation d'un derive de pyridazinone
DE69606609D1 (de) Wandleranordnung für akustische Abbildung
ES2187552T3 (es) Un sistema de medicion, principalmente ambulatoria, por medio de un electrodo.

Legal Events

Date Code Title Description
KB Patent renewed
FF Patent granted
KB Patent renewed